BackKorsana Biosciences Overview

Korsana Biosciences Receivables

Korsana Biosciences's receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
↓ 100.00% YoYΔ $-100000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Korsana Biosciences Receivables History

Loading

Korsana Biosciences vs. peers: Receivables Comparison

Loading

Korsana Biosciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Korsana Biosciences (KRSA) FAQ

Korsana Biosciences (KRSA) currently reports a receivables of $0 as of September 2026. That compares with $100K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Korsana Biosciences's receivables history and peer comparisons.

Korsana Biosciences's receivables decreased from $100K to $0 — a 100.0% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Korsana Biosciences reported $0 in receivables as of September 2026. That compares with $100K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Korsana Biosciences, and consider following KRSA for alerts when major investors trade the stock.

Korsana Biosciences is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KRSA with unrelated industries.